OOIR: Observatory of International Research

Papers

(The H4-Index of JNCI-Journal of the National Cancer Institute is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Correction to: ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications	331
RE: Use of artificial intelligence for cancer clinical trial enrollment	196
Dyslipidemia and cardiovascular disease among childhood cancer survivors: a St. Jude Lifetime Cohort report	141
Vertical integration in oncology: what does it mean for patients with cancer?	128
Understanding risk factors for endometrial cancer in young women	128
Method of primary breast cancer detection and the disease-free interval, adjusting for lead time	123
Re: Deng and Heybati	123
Addressing Diversity, Equity, and Inclusion at the JNCI Journals	122
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer	114
The Unrelenting Impact of Poverty on Cancer: Structural Inequities Call for Research and Solutions on Structural Determinants	110
The National Cancer Institute Funding of Global Research: Lessons Learned and Opportunities Going Forward	106
Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020	86
RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers	69
Evaluating a blood test for colon cancer screening: how simulation modeling can inform clinical policy making and research	66
Li-Fraumeni Syndrome in the Cancer Genomics Era	64
Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination	62
Response to Liu and Zhang	62
Pre- and post-diagnostic use of antihypertensive medications and stage I-III colorectal cancer survival: prospective cohort study	61
Medication–Associated Phthalate Exposure and Childhood Cancer Incidence	61
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study	60
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial	59
Long-term aspirin use and cancer risk: a 20-year cohort study	57
Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a US cohort	52
Mediators of Racial Disparities in Heart Dose Among Whole Breast Radiotherapy Patients	52
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment	49

Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer	48
Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities	48
Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study	47
Impact of knowledge of human papillomavirus positivity on cervical cytology performance in Latin America	46
Determinants of late metastases in renal cell carcinoma	45
Treatment deescalation for older women with favorable breast cancers: patient values and shared decision making	43
Response of bilateral Wilms tumor to chemotherapy suggests histologic subtype and guides treatment	43
Patients’ attitudes and preferences toward delayed disease progression in the absence of improved survival	42
Behavioral Research in Cancer Prevention and Control: Emerging Challenges and Opportunities	42
Cancer control co-benefits of the climate-related provisions in the American Inflation Reduction Act	42
An Artificial Intelligence System for the Detection of Bladder Cancer via Cystoscopy: A Multicenter Diagnostic Study	42
RE: Prevalence of cancer survivors in the United States	41
Optimizing public-private partnerships to support clinical cancer research	41
Evaluating colonoscopy quality by performing provider type	41
Contribution of health insurance to racial and ethnic disparities in advanced-stage diagnosis of 10 cancers	41
Correction to: Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study	40
Dietary interventions in cancer: a systematic review of all randomized controlled trials	40